Original articleAdult cardiacEffect of Hospital Ownership on Outcomes After Left Ventricular Assist Device Implantation in the United States
Section snippets
Data Source
The source of data was the National Inpatient Sample (NIS) of the Healthcare Utilization Project (HCUP), sponsored by the Agency for Healthcare Research and Quality, a large all-payer database of hospital inpatient stays in the Unites States (US). The details and description of the design of the sample has been previously described and its available online [12]. Discharge data set from a 20% stratified sample of US hospitals are recorded in the NIS, which is a part of the HCUP [12]. In a
Patient Characteristics
The main baseline patient-and hospital-level characteristics are presented in Table 1. We identified 3,571 LVAD implants (weighted, 17,547) between 2009 and 2014. The implant in 82.1% of patients occurred in not-for-profit hospitals, 15.6% in nonfederal government hospitals, and 2.3% in for-profit hospitals (Table 1). Patients who underwent the implant in for-profit hospitals were significantly older than those whose implant occurred in nonfederal government and not-for-profit hospitals. We did
Comment
In our current study, we determined that outcomes differed based on the type of hospital ownership among the LVAD implants performed from 2009 to 2014 using a nationally representative sample. Specifically, we found increased in-hospital mortality after LVAD implantation among for-profit hospitals, significantly higher rates of nonroutine discharge and discharge to extended-care facility among not-for-profit hospitals, and higher median cost of hospitalization in nonfederal government hospitals.
References (20)
- et al.
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
Ann Thorac Surg
(1999) - et al.
Eighth annual INTERMACS report: special focus on framing the impact of adverse events
J Heart Lung Transplant
(2017) - et al.
HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients
J Am Coll Cardiol
(2010) - et al.
INTERMACS database for durable devices for circulatory support: first annual report
J Heart Lung Transplant
(2008) Hospital ownership type and treatment choices
J Health Econ
(2012)- et al.
Effect of hospital ownership on outcomes of heart failure hospitalization
Am J Cardiol
(2017) - et al.
Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score
J Am Coll Cardiol
(2013) - et al.
Impact of center left ventricular assist device volume on outcomes after implantation: an INTERMACS analysis
JACC Heart Fail
(2017) - et al.
Institutional volume of heart transplantation with left ventricular assist device explantation influences graft survival
J Heart Lung Transplant
(2014) - et al.
HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation
N Engl J Med
(2007)
Cited by (7)
Cost-effectiveness of using hepatitis C viremic hearts for transplantation into HCV-negative recipients
2021, American Journal of TransplantationEffect of Hospital Characteristics on Performance of Pediatric Digit Replantation in the United States
2023, Journal of Hand and MicrosurgeryHypothyroidism Is Associated With Longer Hospital Stay Following Implantation Of Left Ventricular Assist Device
2021, Clinical Medicine Insights: CardiologyPediatric intrathecal baclofen pumps: A descriptive analysis of hospital course and associated costs
2021, Pediatric Neurosurgery